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Summary 
The major histocompatibility complex (MHC) class II-associated invariant chain (Ii) is thought 
to act as a chaperone that assists class II during folding, assembly, and transport. To define more 
precisely the role of Ii chain in regulating class II function, we have investigated in detail the 
biosynthesis,  transport, and intracellular  distribution of class II molecules in splenocytes from 
mice bearing a deletion of the Ii gene. As observed previously, the absence of Ii chain caused 
significant reduction in both class II-restricted antigen presentation  and expression of class II 
molecules at the cell surface because of the intracellular accumulation of ot and/3 chains. Whereas 
much of the newly synthesized  MHC  molecules  enter a high molecular weight aggregate 
characteristic of misfolded proteins, most of the ot and/3 chains form dimers and acquire epitopes 
characteristic of properly folded complexes. Although the complexes do not bind endogenously 
processed peptides, class II molecules that reach the surface are competent to bind peptides added 
to the medium, further demonstrating that at least some of the complexes fold properly. Similar 
to misfolded proteins, however, the ot and/3 chains are poorly terminally glycosylated, suggesting 
that they fail to reach the Golgi complex. As demonstrated by double label confocal and dectron 
microscope immunocytochemistry, class II molecules were found in a subcompartment of the 
endoplasmic reticulum and in a population of small nonlysosomal vesicles possibly corresponding 
to the intermediate compartment or c/s-Golgi network. Thus, although c~ and B chains can fold 
and form dimers on their own, the absence ofli chain causes them to be recognized as "misfolded" 
and retained in the same compartments as bona fide misfolded proteins. 
M 
HC class I and II molecules bind peptide antigens and 
present them to T cells (1-4). Whereas class I mole- 
cules predominantly bind peptides generated from endogen- 
ously synthesized cytosolic proteins before their release from 
the endoplasmic reticulum (ER)  1 (4--6), class II MHC mol- 
ecules present  internalized processed antigen (7-9). 
Class II molecules are expressed on the cell surface as het- 
erodimers composed of 34-kD c~ and 28-kD/3 chains (10). 
The r  and/3 chains also interact with a third glycoprotein, 
the invariant chain (Ii), after their translocation into the ER 
(11, 12). Recently, it has been shown that the Ii and or/3 het- 
erodimers form a nonamer structure consisting of three Ii 
and three c~/3 heterodimers before their exit from the ER (13). 
The (ot/3Ii)3 complex is then transported through the Golgi 
1 Abbret,  iatiom used in this paper: CGN, cis-Golo network; EM, dectron 
microscopy;  ER, endophsmic reticulum; li, invariant chain; PAS,  protein 
A-Sepharuse; TGN, tra~-Golgi network. 
apparatus to an acidic compartment where the Ii is proteo- 
lyrically removed before class II expression on the cell surface 
(11,  14). 
Current models suggest that Ii may have several functions 
in class II-restricted antigen presentation.  First, Ii may serve 
as a chaperone that plays an essential role in the initial folding 
and olignmerization of newly synthesized  ot and/3 chains 
in the ER. Second, Ii chain may act to target the transport 
of class II molecules from the ER to the trans-Golgi and then 
to an endosomal compartment where the complexes  encounter 
exogenous proteins that have been internalized and processed 
to peptide antigens (4, 15). In support of this possibility is 
the recent finding that the Ii cytoplasmic domain may con- 
tain a specific endosomal targeting or retention signal (15, 
16). Third, Ii may prevent the premature association of pep- 
tides with "empty" class II molecules while in transit to en- 
dosomes (17-20). Evidence to support this possibility comes 
from examination of the peptides bound in vivo to HLA-DR 
or/3 and ot/3Ii complexes. Whereas peptide fragments were 
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were detected with ot/3Ii complexes (19, 20). Similarly, free 
peptides have been shown to bind only to or/3 and not to 
ot/3Ii complexes (19, 20). By affecting the folding, assembly, 
and competence for peptide binding or intracellular  trans- 
port of dass II molecules, Ii directly affects class II-restricted 
antigen  presentation. 
Attempts to define the precise function or functions of the 
Ii by analyzing  the behavior of class  II molecules with or 
without Ii in transfected cells have yielded conflicting results 
depending on the type of cells transfected and/or the protein 
antigens tested (17, 21-24). More recently, it has become pos- 
sible to analyze the role of Ii chain in authentic dass II-posi- 
rive cell types by using homologous recombination to delete 
the Ii chain gene in murine embryonic stem cells (25, 26). 
Deletion of the Ii chain gene was found to greatly diminish 
the ability of splenic B cells to present  exogenous antigen 
in a class II-restricted fashion in vitro and to reduce the matu- 
ration of CD4 + T cells in vivo. These effects reflected an in- 
ability of class II molecules to acquire antigenic peptides from 
endogenously processed proteins, Surface expression was also 
markedly reduced, with class II molecules accumulating in- 
tracellularly early in the secretory pathway. However, the ac- 
tual site of accumulation remains to be established.  Moreover, 
it is unclear whether intracellular accumulation of the c~ and 
/3 chains reflected a role for Ii chain in folding and assembly 
of newly synthesized class II molecules or a role in facilitating 
the transport  of properly assembled o~//3 dimers. 
In this paper, we examine in greater detail the mechanisms 
responsible for the cellular phenotype associated with dele- 
tion of the Ii chain  gene.  Using a series  of independently 
constructed recombinant  mice, we have performed double 
label immunocytochemistry to precisdy define the site at which 
ot and/3 chains accumulate in the absence ofli chain. Moreover, 
we have analyzed the kinetics of synthesis, assembly, and trans- 
port of MHC class II molecules in these mice. Our results 
show  that  although  the  ot  and  /3  chains  are  capable  of 
significant assembly and folding, they are largely retained by 
the quality control system of the ER/intermediate compart- 
ment/c/s-Golgi network (CGN) as typical "misfolded" pro- 
teins.  Since the class II molecules also fail to acquire endoge- 
nous peptides,  this defect is more likdy to reflect their inability 
to be delivered to the intracellular site(s) where suitable pep- 
tides are encountered, as opposed to a direct role of Ii chain 
in regulating  assembly or peptide binding. 
Materiah  and  Methods 
Gene Targeting and Embryonic Stem Cells.  A 2.1 kb BglII-EcoRI 
fragment encoding the promoter and exon 1 was subdoned into 
pSK Bluescript (Stratagene, La Jolla, CA). The internal 0.4 kb StuI 
fragment was deleted and the neomycin resistance cassette (pMClneo 
PolyA, Stratagene) was introduced in place of the StuI fragment. 
An additional 3.0-kb EcoRI-KpnI ftagmeut encoding e~ons 2 and 
3 was added to the Y end of the BgllI-EcoRI subclone. Finally, 
two copies of the HSV-1 thymidine kinase geue were subdoned 
into the NotI polylinker site 5' of the Ii geue. ES-D3 cells (107) 
in 0.7 ml of media were transfected with 25/~g of NotI linearized 
DNA with a geue pulser (25 ~F, 0.32 kV; Bio-Rad Laboratories, 
Cambridge, MA). After electroporation,  the cells were plated on 
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10 100-ram plates in media (DMEM with 15% FCS, 2 raM gluta- 
mine, and 0.1 mM 2-ME) supplemented with leukemia inhibitory 
factor (Gibco BRL, Gaithcrsburg, MD). Media with geneticin (170 
~tg/ml;  Gibco BILL) and gancyclovi~  (2/~M; Syntex,  Palo  Alto, 
CA) was  added  24  h after  transfection.  All  transfectants  were  main- 
tained  on a  monohyer of  I  ~  embryonic  fibroblasts  during  the  10-d 
drug selection.  Genomic DNA  was  purified  from individual  clones 
and analyzed by Southern blot with a 5' probe (see solid box, Fig. 
1 A). This probe is a 0.6-kb BgllI-XbaI fragment from the 5' end 
of the Ii gene. It hybridizes to a 3.0-kb EcoRI fragment  of the 
endogenous Ii gene and to a 2.5-kb fragment oftbe disrupted allele. 
Cell Sue'ace Expression by Flow Cytometric Analysis.  5  x  10  s 
freshly prepared splenocytes were incubated on ice with saturating 
amounts  of biotin-conjugated  anti-I-A  b antibodies for 20 min in 
staining buffer (PBS with 1% FCS) in a total vohme of 100/~1. 
The wells were washed twice with staining buffer and incubated 
with the appropriate avidin FITC-conjugated second step reagent. 
Finally, the cells were washed, fixed with 1% paraformaldchyde, 
and analyzed by flow cytometry on a FACS Star  Q (Becton Dick- 
inson & Co., Mountain  View, CA).  The primary  Ab Y-Ae was 
generously provided by Dr. Charles Janeway. M5/114 (27, 28)was 
from American Type Culture Collection (Rockville, MD) and AF6- 
120.1 was from PharMingeu  (San Diego,  CA). 
Pulse-chase Labeling.  Before radiohbeling,  Ii + or AIi cells were 
incubated for 1-2 h in methionine-deficient cx-MEM supplemented 
with 5% dialyzed FCS. The cells were then pelleted and resuspended 
in the same medium at 4  x  107/ml and metabolically labeled by 
a 20-min pulse incubation with 1 mCi/ml [3SS]methionine trans- 
labd (ICN Biomedicals Inc., Costa Mesa, CA).  After the pulse, 
the  cells were pelleted,  unincorporated  radiohbel  removed by 
washing, and the cells were resuspended at 2  x  I(Y  s cells/m1 in 
ice-cold (0 chase) or prewarmed o~-MEM  containing 5% FCS. The 
cells in the prewarmed media were then incubated for 0.5,  1, 2, 
4, or 6 h at 37~  in a 5% COz atmosphere. 
Immunoprecipitations.  After the pulse-chase, the cells were pel- 
leted and lysed in 0.5% Triton X-100, 300 mM NaC1, 50 mM Tris, 
pH 7.4, 1 mM PMSF, leupeptin,  10/zg/ml aprofinin,  10/~g/ml 
pepstatin,  10/zg/ml chemostatin,  and 20 raM N-ethyhnaleimide 
(NEM). Nuclei and debris were eliminated by centrifugation.  The 
cell lysates were precleared first, by an  incubation  with  rabbit 
anti-mouse IgG (Zymed Laboratories, S. San Francisco, CA) and 
Staph A (Pharmacia, Piscataway, NJ) overnight at 4~  second by 
a  1-h incubation  with  Staph A,  and  finally, 1 h  with protein 
A-Sepharose (PAS) at 4~  MHC class II molecules were then 
precipitated by incubating the lysates  for 1 h at 4"C with PAS which 
had been previously bound to either goat anti-rat IgG and M5/114 
mAb or to Y3P mAb.  PAS/Ab/chss II aggregates were washed 
three times in 0.5% NP40, 30 mM NaC1, 50 mM Tris, pH 7.4. 
The beads were then resuspended in l.aemli sample buffer containing 
3% SDS and either incubated for 1 h at room temperature or boiled 
for 3 rain. 
The immunoprecipitates were analyzed by electrophoresis using 
11% SDS-PAGE  mini-gds (Hoeffer Scientific Instruments, San Fran- 
cisco, CA).  The gels were treated with salicilate, dried,  and ex- 
posed to autoradingraphy  film (Eastman Kodak Co., Rochester, 
NY) and quantified by image digitization using an image processor 
(Bio-Image 2000; Eastman  Kodak Co.). 
Confocal Immunofluorescence MicroscoF/.  Splenocytes  were treated 
for 48 h with 10/ag/ml LPS (Sigma Chemical Co., St. Louis, MO). 
After  stimulation,  cells were washed twice,  attached  to Aldan 
blue-coated cover slips, fixed with 2% formaldehyde, and permea- 
bilized with PBS containing 0.1% gelatin and 0.01% saponin. The 
cells were stained with primary Ab and affinity-purified secondary 
Ab and then imaged on a confocal microscope (model MRC600; 
Ii Chain and MHC II Transport Bio-Rad Laboratories). The primary Abs used were, rabbit anti- 
serum raised to afffinity-purified  I-A  a (Rb anti-I-M, a generous gift 
of Dr. Ralph Kubo), the FcTRII-specific mAb 2.4G2 (29), the Ii- 
spedfir mAb In-1 (a generous gift of Dr. Jim Miller) (30), anti- 
Igp110 mAb GL2A7 (31), rabbit antimannosidase  II sen (a generous 
gift of Dr.  I~lley Moremen)  (32), rabbit  anti-TGN-38 (33) (a 
generous gift of Dr. George Banting), and an anti-BiP mAb (34) 
(a kind gift of Dr. David Bole). 
Electron Microscopy  Immunocytochemistry  Using Ultmthin  Frozen  Sec- 
tions.  Since  the morphology of isolated splenocytes was judged 
to be inferior, all immunodectron microscopy  was performed using 
sections prepared directly from intact spleens. Organs were fixed 
by in situ perfusion using 4% paraformaldehyde in PBS, minced, 
and processed for ultracryomicrotomy by established methods de- 
scribed in detail elsewhere (35, 36). Briefly, tissue pieces were 
cryoprotected in 2.1 M sucrose in PBS for at least 1 h, mounted 
onto specimen pins, and frozen by immersion in liquid nitrogen. 
Tissues that did not hold together well during manipulation were 
embedded in 10% gehtin before cryoprotection and freezing. Ultra- 
thin sections for electron microscopy (EM) were cut at  -100~ 
using a Leica/Reichert Ultracut-FC4 system (Leica, Deerfield, IL) 
with either a diamond or a glass knife. Sections  were retrieved from 
the dry surface of the knife with a drop of 2.3 M sucrose and trans- 
ferred onto formvar-carbon coated copper or nickel grids (Gilder 
grids; Electron Microscopic  Supplies, Ft. Washington, PA) and im- 
munolabeled using previously described procedures (35). The sec- 
tions on the grids were then washed with distilled water, floated 
for 10 min on ice-cold drops of 1.8% aqueous methyl cellulose  con- 
taining 0.3%  uranyl acetate, and finally dried in a film of methyl 
ceUulose-uranyl  acetate mixture. The sections were examined and 
electron micrographs taken using an electron microscope (model 
EMM410; Philips Electronic Instruments Inc., Mahway, NJ) oper- 
ating at 80 kV. 
Results 
Generation of Invariant Chain-deficient Mice.  A  germline 
transmitting line of mice deficient in expression of Ii was 
generated using gene targeting and embryonic stem cell tech- 
nology. A total of 107 ES-D3 cells were electroporated with 
a gene targeting construct, pIiKO (Fig.  1 A). After sdec- 
tion,  1.4  x  103 G418-resistant colonies were recovered; of 
these, 3  x  102 transfectants were also resistant to gancy- 
dovir. A total of 60 doubly resistant clones were tested by 
Southern blot analysis. Two clones were identified as having 
incorporated the targeting vector by homologous recombi- 
nation. Both clones were tested with a series of restriction 
enzymes to confirm that they contained a single insertion 
of the targeting construct. One done, containing a disrupted 
Ii allele, was injected into C57BL/6 blastocysts. A total of 
eight male chimeras were born and then bred. One of the 
male chimeras transmitted the ES cell genotype to 100% of 
its offspring. As determined by Southern blot analysis of tail 
DNA (Fig.  1 A), approximately one half of the offspring 
contained one disrupted Ii allele (+/-).  Of the F2 animals 
derived from heterozygous brother  x  sister mating,  one 
quarter of the progeny were homozygous for the Ii gene mu- 
tation (-/-). 
To confirm the loss of Ii protein expression, we examined 
LPS-treated splenocytes from heterozygous (Ii +), or mutant 
(AIi) mice by immunofluorescence  confocal microscopy using 
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the Ii-specific  Ab, In-1 (30).  As shown in Fig.  1 B (In-l), 
the Ii +  splenocytes expressed normal levels of Ii.  As  ex- 
pected, no Ii expression was detected either on the plasma 
membrane or in any intraceUuhr compartments in LPS-treated 
splenocytes from the AIi mice. These results establish that 
the deletion of exon 1, of the Ii gene, results in the loss of 
protein expression. 
Ii Gene Disruption Leads to Decreased  Expression of Class II 
Molecules on the Cell Surface  To determine whether the loss 
of Ii expression had any effect on the expression of class II 
cx and/3 chains, we next performed flow cytometric analysis 
of splenic lymphocytes. As detected by a pand of mAbs specific 
for either Aa  b or Ac,  b, or a polydonal antisera, splenocytes 
from the AIi mice exhibited a 5-10-fold reduction in the level 
of class II staining on the plasma membrane (Fig.  2, A  and 
B,  Ii +,  dashed line; AIi,  solid line). Since  the  Abs  used 
(M5/114 and a polyclonal anticlass II Ab) do not distinguish 
different conformations of class II molecules (17, 37), the ob- 
served decrease in staining was likely to reflect an actual de- 
crease in number of cell surface class II epitopes. This was 
surprising given suggestions that the Ii is not required for 
cell surface expression of class II molecules in transfected fibro- 
blasts (18, 23, 37), but is in accord with transfection experi- 
ments that have implied a role for Ii in exit from the ER 
(12,  15,  17),  and is also in agreement with the results ob- 
tained for other AIi mice (25,  26). 
The ability of the Ii + and AIi splenocytes to process/pre- 
sent intact Eot-containing fusion protein versus exogeneously 
added Fax peptide was examined by antigen presentation assays 
in vitro. Ii + cells were proficient at presenting both exoge- 
nous peptide as well as intact protein antigen. In contrast, 
APCs from our Ii KO mice showed a defect in their ability 
to present intact protein while being proficient at presenting 
exogenous peptide antigens (data not shown). Since both live 
and fixed splenocytes were capable of presenting peptide, these 
results demonstrate that those class II molecules that reach 
the plasma membrane are capable of productively binding 
antigenic peptide despite the absence of Ii chain. 
Moreover, it was apparent that a significant fraction of class 
II molecules on the surface of AIi splenocytes were "empty", 
i.e.,  devoid of bound peptide. We compared the ability of 
Ii + and AIi splenocytes to bind an Eot peptide by measuring 
cell surface staining with Y-Ae after incubation with Eot pep- 
tide. Y-Ae is a monoclonal alloantibody that detects a deter- 
minant expressed on a subset of class II I-A  b molecules when 
complexed with an Ec,-derived peptide Ea56-73  (38-40). 
AIi and Ii + splenocytes were incubated with Eot peptide 
for 4 h and then stained for the Y-Ae determinant. Both Ii + 
(Fig. 3, dashed line) and AIi (Fig. 3, solid line) cells expressed 
the Y-Ae epitope. However, the AIi cells showed a substan- 
tially higher degree of staining with Y-Ae Ab than did the 
Ii + cells which is striking given that the AIi cells actually 
express 5-10-fold fewer class II molecules on their cell sur- 
face than the Ii + calls. This finding is consistent with the 
prediction that a greater fraction of surface class II molecules 
on AIi cells were empty and therefore capable of binding a 
greater amount of Eot peptide. This suggestion is also con- 
sistent with the antigen presentation results in which the AIi A 
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Figure  1.  Gene targeting of the 
Ii gene and germline transmission 
of the disrupted allele. (A) A sche- 
matic of the Ii gene targeting con- 
struct is shown above the endoge- 
nous Ii gene. (AIi::neo) Mutated Ii 
allele. (Open boxes) Exons and re- 
strict-ion  enzymes as indicated. The 
Southern blot analysis shown is a 
hybridization  of the  Ii probe  to 
EcoRI digested tail DNA from lit- 
termates derived from the mating 
of two heterozygous  +/-  Ii mice. 
Hybridization with the 5' Ii probe 
identifies animals that are homozy- 
gous  wild type  (+/+),  heterozy- 
gous (+/-), or homozygous for the 
disrupted Ii allele (-/-). The 3.0- 
and  2.5-kb  markers  indicate  the 
migration of the wild-type and mu- 
tated alleles, respectively. (B) Con- 
focal  microscopy  of  LPS-treated 
splenocytes  from  heterozygous 
(+/-)  and  homozygous  (-/-) 
using an invariant chain-specific  an- 
tibody, In-L The cells were imaged 
in a Bio-Rad confocal microscope. 
cells were found to present the exogenous peptide better than 
the control cells (data not shown), and it is in general agree- 
ment  with  previous  work  (25,  26). 
Assembly and Folding of Class II Molecules in the A Ii Sfleno- 
cytes.  It seemed likely that the reduction in class II expres- 
sion on the splenocyte plasma membrane reflected  a decrease 
in transport  of newly synthesized oe and 3  chains from the 
ER to the cell surface,  as found for other Ii chain-deficient 
mice (25,  26).  The previous studies were unclear,  however, 
as to whether the decrease in transport correlated  with a de- 
crease in the kinetics or ef~ciency of folding of newly syn- 
thesized o~ and  3  chains.  Accordingly,  we next performed 
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Figure 2.  Flow cytometric anal- 
]isis of MHC dams II ~pression on 
splenocytes  of  II-defident  mice. 
Splenic  single cell suspensions  were 
made from individual Ii + (dashed 
line)  and AIi (solid  line)  animals. 
5  ￿  10  s ceils were  stained with 
class II-slx~/fic  ^bs MS/114 (,4)  and 
AP120.6 (B). In addition to M5/114 
and AF120.6, other class II-specific 
Abs (Y3P, Y248, Y219, Y237, and 
a polyclonal rabbit anti-IA  d) (40) 
were used to stain splenocytes. A11 
Abs tested gave similar results. 
a more complete kinetic analysis of the synthesis and assembly 
of dams II molecules in the presence or absence of Ii chain. 
Splenocytes were briefly pulse labeled (20 rain) in [3SS]me- 
thionine and then chased in medium containing excess unla- 
baled methionine for 0.5-6 h. At various time points, cells 
were harvested and class II molecules immunoprecipitated 
using mAbs that selectively detect either total or assembled 
complexes. Immunoprecipitates were analyzed by SDS-PAGE 
under no,educing conditions with or without boiling be- 
fore dectrophoresis, to determine the rate at which peptide 
loaded,  and thus SDS stable, complexes formed. 
In agreement with previous results (25, 26), splenocytes 
from Ii-deflcient  (AIi) and Ii-heterozygous (Ii +) mice ap- 
peared to synthesize comparable amounts of class II mole- 
cules. As can be seen in Fig. 4 A  (boiled), similar amounts 
of ~ chain were immunoprccipitated from Ii + and AIi cells 
using M5/114,  a mAb that detects all conformations of the 
I-A  b ~  chain  (27, 28).  Moreover,  the  fact  that  M5/114 
coprecipitated  cz chain from both cell types indicated  that 
a significant fraction of the newly synthesized dams II mole- 
cules formed dimers shortly after synthesis in both Ii + and 
AIi cells. The o~ chain band appeared denser than the ~ chain 
band in the immunoprecipitates from the Ii + calls because 
newly synthesized Ii chain comigrates with ol chain under 
the conditions used for these experiments. 
Interestingly, in the AIi cells most of the a/~ dimers were 
found in a high molecular wright complex (Fig. 4 A, top). 
Such aggregates are characteristic of many misfolded proteins 
and indicate noncovalent and disulfide-stabilized interactions 
Y-Ae 
Figure 3.  Enhanced  pcptide 
binding to All-cells. Flow o/to- 
metric analysis  of Y=Ae  expression 
on splenocy~ of li-deficient mice 
pulsed for 4 h with Ea 56-73 lX-p  - 
fide. 5  ￿  10  s splenocytes were 
stained  with the alloanu'body  Y-.~ 
after incubation in the presence  or 
absence of Ea  pcptides.  Back- 
ground staining  was observed for 
both the wild-type and mutant 
ceils in the absence  of peptide (data 
not  shown).  (Dashed he)  Ii+; 
(solid line)  AIL 
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among newly synthesized proteins together with components 
of the ER lumen that are thought to be involved in protein 
folding (41, 42). Indeed, it appeared that the high molecular 
weight complex was stabilized by both covalent and non- 
covalent interactions. Although the c~ and ~ chains were partly 
dissociated by boiling, a significant fraction  of the labded 
dams II molecules remained associated with a narrow band 
of '~250 kD even after treatment at 100~  (Fig. 4 A). Since 
all procedures were performed under nonreducing conditions, 
this was likely to reflect the existence of disulfide bonds be- 
tween at least the ~  chain and itsdf and/or with resident 
ER components. 
In Ii + ceils, only a small fraction of the ot/~ dimers were 
detected in high molecular weight complexes although a 
significant but minor amount of newly synthesized  mole- 
cules were transiently associated with a band of 90 kD at 
early time points (Fig. 4 A, bottom). After 1-2 h, however, 
an increasing fraction of oL and ~ chains migrated as a band 
of 52-55 kD (c[oL/~], Fig. 4). By 6 h, this fraction accounted 
for >80% of the total immunopredpitable protein. Since this 
band was completely sensitive to boiling in SDS, it was in- 
dicative of "compact" peptide-loaded  odO dimers (28, 43, 
44). Compact dimers were not observed at any time point 
in the AIi ceUs, indicating that although cz/O dimers could 
form in the absence of Ii chain, these dimers did not produc- 
tively bind peptide.  Interestingly,  two polypeptides  of 6-8 
and 12 kD were present in the Ii + precipitates after boiling, 
which might represent  Ii fragments,  since they were not 
present  in the AIi precipitates. 
The fact that a large fraction of ol and ~ chains entered 
a high molecular weight aggregate in the absence of Ii chain 
suggested that the quality control system of the ER recog- 
nized these chains as misfolded proteins.  This represented 
something of a paradox since newly synthesized c~ and ~ chains 
were correctly folded at least to the extent that they could 
form stable odO dimers.  To further investigate the degree 
to which o~ and ~ chains could fold and assemble in the AIi 
splenocytes, we next analyzed their reactivity with another 
chain-specific mAb, Y3P, which recognizes a conformation- 
dependent epitope.  Y3P precipitates  primarily I-A  b od~- 
dimers, including those already bound to peptide (28, 45). 
As found using the conformation-independent Ab M5/114, 
Y3P precipitated both cr and ~ chains from AIi splenocytes Figure 4.  Kinetics  of SDS-stable 
complex formation. Cytoplasmic 
extracts were  prepared from spleen 
cells  pulse  labeled  for 20 rain. Class 
II molecules  were immunoprecipi- 
tated with either M5/114 (A) or 
Y3P (B). Different  glycosylation  in- 
termediates are also shown. (O) 
Core glycosyhted;  (ll) trimmed  in- 
termediate; (D) terminally  glyco- 
sylated.  Molecular  weight  markers 
are indicated  by the six horizon- 
tal lines shown between the "not 
boiled" and "boiled"  gels for both 
-/-  and  +/-  in A and B. As 
shown, the markers indicate the 
migration  of  the 106, 80, 49.5, 32.5, 
27.5, and 18.5 kD, respectively. 
at  all  time points  (Fig.  4  B,  top).  This provided further 
confirmation that properly assembled odB dimers can form 
in the absence of Ii chain (Fig. 4 B, top). Whereas the dimers 
were also largely found in a high molecular weight aggre- 
gate, the aggregate detected by Y3P was completely sensi- 
tive to boiling. Thus, Y3P only recognized the B chains that 
formed noncovalent aggregates, suggesting that the covalent 
aggregates consist only of misfolded B chains that cannot 
be detected by this conformation-specific Ab. 
As expected, in lysates fxom Ii + splenocytes, YP3 detected 
peptide-loaded compact cx/B dimers (Fig. 4 B, bottom). These 
were found after 1 h of chase and thus appeared at the same 
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independent Ab  M5/114.  Since  only "empty" heat-labile 
dimers were detected by YP3 at early time points in the AIi 
cells (Fig. 4 B, top), the Ab is not specific for Peptide-loaded 
dimers, as has been suggested previously (28, 45).  Interest- 
ingly, however, YP3 failed to immunoprecipitate any class 
II molecules at earlier time points in the Ii + cells (Fig. 4 B, 
bottom), suggesting that YP3 cannot detect dimers that are 
still complexed with Ii chain. 
Class II Molecules Are Not Terminally Glycosylated  in the Ab- 
sence of Ii Chain.  It was also evident from Fig. 4 that al- 
though newly synthesized ce and/3 chains formed dimers in 
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sugar modifications characteristic of traversal  through the 
Golgi complex.  In Ii + cells,  the immature high mannose 
form of/3 chain (Fig.  4, open circles) was rapidly converted 
to a lower mobility terminally glycosylated protein (Hg. 4, 
open squares). These events were initiated within 0.5 h of chase 
and involved the majority of newly synthesized/3 chain, 
whether immunoprecipitated with M5/114 (Fig. 4 A) or Y3P 
(Fig.  4 B).  Similar aherations were exhibited for c~ chain, 
but its comigration with Ii chain made interpretation more 
difficult. 
In contrast, terminal glycosylation of/3 (and o  0  chain in 
AIi splenocytes was both slower and far less efficient. Al- 
though a significant fraction of newly synthesized/3 chain 
was converted to the higher mobility trimmed form (Fig. 
4, closed  squares), this was not evident until 2 h of chase. Only 
a small amount of/3 chain migrated as slower mobility ter- 
minally processed molecules (Fig.  4, open squares), and this 
required chase times of 4  h  (Fig.  4,  A  and B). 
Together, these results indicate that Ii chain was required 
to enable rapid and efficient modification of N-linked sugars. 
Presumably, this reflects the inability of ol//3 dimers associated 
with high molecuhr weight aggregates to be efficiently  trans- 
ported from the EK to the Golgi complex. Whereas trim- 
ming might reflect exposure to mannosidase I which is present 
in "early" Golgi compartments (e.g., CGN),  terminal pro- 
cessing requires exposure to medial cisternae and the trans- 
Golgi network (TGN)  (46). 
IntraceUular  Localization of Class 11 Molecules in A Ii Spleno- 
cytes.  To establish the intracellular distribution of class II 
molecules in AIi splenocytes, we next performed double-labd 
immunocytochemistry at the levels of both fluorescence and 
electron microscopy. For scanning laser confocal microscopy, 
splenocytes were permeabilized with saponin and stained with 
polyclonal or monodonal (M5/114)  antidass II Abs and a 
monoclonal anti-Fc3,KII which is known to labd the cell 
surface of lymphocytes. Strong plasma membrane staining 
was  observed in  splenocytes from  Ii +  ceUs when  stained 
with either the class  II or Fc~RII  Ab  (Hg.  5 A;  the or- 
ange/ydlow color of the merged confocal images indicates 
colocalization of both patterns on the cell surface). In con- 
trast, plasma membrane staining was only observed for FcyRII 
(Fig. 5 red) in AIi splenocytes, with staining for class II mol- 
ecules appearing as a concentric ring contained within the 
FcK surface staining (Fig.  5 B). 
To examine the subceUular distribution of class II mole- 
cuhs relative to  the Ii chain,  in  the Ii + cells,  splenocytes 
were double labded for class II and Ii (Fig.  5,  C  and D). 
In Ii + splenocytes (Fig.  5  C),  a ring of plasma membrane 
staining for class II molecules (green) was observed that en- 
circled the intracellnlar staining of Ii chain (red).  A  small 
amount of colocalization between Ii and intracellular class 
II was also observed. In the double-labeled AIi splenocytes 
(Pig.  5 D), an intracdlular staining pattern for class II was 
again observed. As expected, no Ii staining was seen above 
background. 
To define the intracellular smtctures containing class II mol- 
ecules in AIi cens, we next performed a series of  double labeling 
experiments using  Abs  that  selectively detect  specific  or- 
gandies. The involvement of the endocytic  pathway was first 
analyzed by labding cells for class II and proteins known to 
be localized to endosomes and/or lysosomes. Intracellnlar class 
II was not found to colocalize with Lgp110,  a marker for 
late endosomes and lysosomes (Hg. 5, E  and F), nor with 
functional markers for early endosomes and recycling vesicles 
such as transferrin receptor or internalized complexes of  mem- 
brane Ig and anti-Ig (data not shown). Thus,  the internal 
class II molecules in the AIi splenocytes did not accumulate 
in organefles of the endocytic pathway. 
Figure 5.  Distribution  of  class II molecules  visualized  by double  label 
conkx~ immunofluorescence  microscopy.  LPS-s6.mulated  splenocytes  were 
double stained  with: (A and B) class II mAb M5/114 (red) and l~yKII 
(green); (C and D) polyclonal  class II antisera ~green)  and Inol (red); (E 
and F) polyclonal  class II antisera (green)  and Igp110 (red).  A, C, and E 
are Ii  § cells; B, D, and F are AIi cells. Double staining is indicated  by 
a yellow  color in the merged  images. In the case of F, a white  arrow is 
shown to help visualize the surface  of the cell. 
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class II molecules in AIi cells relative to organeiles of the secre- 
tory pathway. Splenocytes were first double labeled for class 
II (Fig.  5, red) and the TGN marker TGN38 (Fig. 5, green). 
As expected, little if any colocalization was observed in Ii + 
cells since virtually all of the class II molecules were present 
on the call surface (Fig. 6 A). TGN staining was limited to 
a restricted region on one side of the nucleus, corresponding 
to  the pericentriolar region.  In  the AIi  cdls,  however,  a 
significant fraction of the intracdlular class II was found to 
costain with TGN38  (Fig.  6 B, yellow). Given the limited 
resolution of fluorescence microscopy and the limited size 
of the cytoplasmic compartment in splenocytes, these results 
do not indicate that class II molecules were found in the TGN 
but only that a portion of them were found in the same general 
region as the Golgi complex. 
Splenocytes were also  stained for class II and BiP, a resi- 
dent of the ER and intermediate compartment that is thought 
to play a role in protein folding (41, 42, 46).  As shown in 
Fig. 6 C, the patterns of surface class II labding (green) and 
BiP labding of the ER and nuclear envelope (red) were en- 
tirely distinct in Ii + cells. In contrast, considerable colocali- 
zation of BiP and class II was observed in the AIi ceUs (Fig. 
6 D, orange~yellow). A region to one side of the nucleus, pre- 
sumably corresponding to the pericentriolar region, also con- 
tained an area of class II staining that was relatively devoid 
of BiP. This region could represent class II localized to the 
Golgi complex or to intermediate compartment structures 
that have relatively low concentrations of BiP. 
Localization of  lntracellular Class II Molecules by Iramunoelec- 
tron Microscot~.  Since even confocal microscopy was of too 
limited resohtion to permit a definitive assessment of the 
intraceUular localization of class II molecules in AIi spleno- 
cytes, we next used protein A-gold immunocytochemistry 
on ultrathin frozen sections. Spleens were perfusion fixed in 
situ with 4%  paraformaldehyde, cryoprotected in sucrose, 
frozen in liquid nitrogen, sectioned, and then stained using 
a polydonal antidass II Ab. To mark dements of the rough 
ER and intermediate compartment, the sections were also 
double labded with a monoclonal anti-BiP Ab. As shown 
in Hg. 7, considerable labeling of  morphologically identifiable 
ER dsternae was observed for both class II (5 nm gold) and 
BiP (10 nm gold) in AIi splenocytes (Fig.  7 A, arrow). As 
expected, some class II labeling was observed on the plasma 
membrane. Large class II- and BiP-positive vesicular struc- 
tures corresponding morphologically to forming autophagic 
vacuoles were also  observed (arrowhead). 
In addition to conventional rough ER,  class II staining 
was often found in a heterogeneous population  of resides 
and tubules that were positive for BiP (Fig. 7 B, arrowheads). 
Based on the more extensive analysis  of a variety of model 
systems (41, 42, 46), it is likely that these noncisterual ele- 
ments represent the intermediate compartment or CGN (47) 
in which misfolded or ER proteins are retained or retrieved 
and returned back to the ER proper (41, 42, 46). Unfortu- 
natdy,  it  proved impossible to  labd  the splenocytes with 
Abs to rab2, p53, or p58, intermediate compartment/CGN 
markers, since none of these Abs was sufl~dently  reactive with 
murine calls.  In  Ii +  splenocytes,  similar  patterns  of BiP 
staining were observed, although the BiP-positive compart- 
ments were not heavily labded for dass II molecules (data 
not shown). 
Figure 6.  Distribution  of class II molecules  rehtive to the TGN and 
ER. (A and B) Anti-class  II mAb M5/114 (red)  and antibody  to the TGN 
marker  TGN38 (green);  (C and D) polyclonal  anti-class  II antisera  (green) 
and mAb anti-BiP  (red).  Coincident  staining  is marked  by a yellow/orange 
color. 
Discu~on 
Despite considerable interest, the precise role of Ii chain 
in the synthesis, transport, and function of class II molecules 
has remained unclear. In an effort to provide a new approach 
to this problem, we employed the recently developed tech- 
nique of homologous recombination in embryonic stem cells 
to create a germline transmitting line of mice which con- 
tains a ddetion within the coding region of the invariant chain 
gene. Our results concerning the immune and cellular pheno- 
types of Ii-defident mice are in good agreement with recently 
published work utilizing independently generated strains of 
recombinant mice (25, 26). In general, it is clear that dele- 
tion of the Ii chain gene leads to an overall reduction in the 
expression of  class II molecules on the plasma membrane and 
to their intracdlular accumulation, presumably early in the 
secretory pathway. The few class II molecules that do reach 
the  plasma  membrane  do  not  acquire  peptide  from  en- 
dogenously processed antigens but can bind peptide added 
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BiP to the ER of AIi splenocytes  by immunoelec- 
tron microscopy  of  frozen  thin sections. After fixa- 
tion by in situ perfusion with paraformaldehyde, 
spleens from Ali mice were cryoprotected,  frozen, 
and ultrathin sections stained with Abs to class 
II (5-nm gold parddes) and BiP (10-nm gold par- 
tides). (A) Extensive  hbding of  cistemal dements 
of  the rough Elk with both anti-BiP and anti-chss 
II reagents; (arr0tv/~ a likely  autophagic  vacuole 
forming  from ER. elm",mts. (/3) Labeling  of  tubular- 
vesicular structures characteristic of the "inter- 
mediate compartment" between the Etk and the 
Golgi complex (or CGN-transitional dements) 
(47). (Arrows) Positive  EP, and continuous nuclear 
envelope dements,  x 71,300. 
to the culture medium. Finally, these alterations are accom- 
panied by a marked decrease in the ability of AIi splenocytes 
to present antigen to T cell hybridomas in vitro and appar- 
ently to CD4 + T  cells  in vivo. 
Together, these results demonstrate that Ii chain plays a 
critical role in regulating the class II-restricted immune re- 
sponse. Since it seemed likely that the phenotypes associated 
with Ii chain deletion were secondary to a defect in the folding, 
assembly, or intracdlular transport of class II molecules, we 
determined the cell biological basis for the defects caused by 
Ii chain ddetion in primary splenocytes. Surprisingly, we found 
that Ii chain is not required for the dimerization or at least 
partial folding of or and 13 chains, but is nevertheless required 
to allow newly synthesized class II molecules to escape the 
quality control mechanism in the ER that prevents the trans- 
port  of misfolded proteins. 
MHC Class II Molecules Fold and Assemble Properly in the 
Absence of Ii Ckain.  We found that splenocytes from AIi 
mice synthesized o~ and B chains, and assembled them into 
dimers, in a fashion indistinguishable from Ii + sphnocytes. 
Abs to a conformation-independent determinant on the 
chain (M5/114)  were found to coprecipitate cx chain with 
similar d~ciencies from both cell types. This was in accord 
with the observations of Viville et al. (26) but distinct from 
Bikoff et al.  (25)  who reported that dimer formation was 
markedly inhibited in AIi ceils. Reasons for this discrepancy 
might reflect differences in the ei~ciencies or conditions of 
immunoprecipitation. In addition, Bikoff et al. used M5/114 
as a dimer-speciiic reagent whereas we have found it to react 
wet1 with free B chain even by Western blot (Drake, J. R., 
unpublished observations).  In any event, it is clear that at 
least some dimer formation must occur since empty but rune- 
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brane of AIi splenocytes from all three sets of mice. 
The question of dimer formation is critical since it per- 
tains directly to whether Ii has a role in the folding and/or 
assembly of new synthesized a  and/3 chains, a function sug- 
gested by a variety of observations using class II-transfected 
fibroblasts (18). Not only did we find effident coprecipita- 
tion of c~ and/3 chain in pulse-labeled cells, but the class II 
molecules formed were reactive with the dimer-specific Ab 
YP3. This indicated that both c~ and/3 chains were capable 
of extensive folding and formed "authentic" dimers in the 
absence of Ii chain. The YP3 epitope appeared very rapidly 
in AIi ceUs and was fully expressed by the end of the 20-min 
chase, in accord with the kinetics of the assembly of class 
II-Ii chain complexes in Ii + calls (15, 24, 48). Interestingly, 
or//3 dimers became reactive with YP3 in AIi cells more rap- 
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idly than in Ii + cells in which YP3  immunoprecipitation 
was evident after peptide-loaded, SDS-stable  complexes began 
to appear (>l-h chase). This also corresponded  to the time 
at which Ii chain dissociation would be expected to occur 
(15, 19, 24, 48). Since ol/B dimers in AIi cells remained SDS 
sensitive and presumably empty of  peptide at all time points, 
it seems likely that YP3  recognizes a determinant that is 
masked by bound Ii chain and therefore  is accessible  immedi- 
ately upon dimerization of cz and/3 in the AIi cells. 
Ii Chain Is Required to Evade the Quality Control Mechanisms 
in the ER.  Since  newly synthesized class II molecuhs ex- 
hibited extensive folding and dimerization in the absence of 
Ii chain, it was surprising  to find that they failed to escape 
the ER mechanisms designed to prevent the forward trans- 
port of  misfolded membrane and secretory proteins. Immedi- 
ately after their formation, ot and/3 chains entered a high molecular weight aggregate that persisted for long times of 
chase. Such aggregates are typical of many misfolded pro- 
reins and are thought to reflect the formation of stable com- 
plexes between newly synthesized proteins and intrinsic ER 
components that are involved in protein folding (41, 42). Al- 
though such components typically include proteins such as 
BiP, calnexin (I>88), and protein disulfide isomerase, the other 
members of the novel class II-contaiuing aggregates observed 
in the AIi cells remain to be identified. It is conceivable that 
homotypic interactions among class II molecules themselves 
at least in part explains the formation of the high molecular 
weight complexes. 
Such aggregates need not reflect a "dead-eud" pathway for 
misfolded proteins, but rather may represent the formation 
of folding intermediates  with ER components that are in- 
volved in the normal folding pathways of many membrane 
proteins (41, 42). Thus, the entry of newly synthesized class 
II molecules into high molecular weight complexes may nor- 
mally be an intermediate step in the addition of Ii chain to 
the nascent c~/~/Ii nonamer (13). Addition of three Ii chains 
to the forming complex may be a prerequisite for its rdease 
from the aggregate, possibly explaining why otherwise folded 
ot/B dimers might accumulate at this step in AIi splenocytes. 
In favor of this possibility is the observation that a small frac- 
tion of class II molecules synthesized even in the Ii + spleno- 
cytes was found in a high molecular weight complex. 
It is also apparent  that at least two types of interactions 
lead to the formation of the class II-containing complea~s. 
One interaction is dearly noncovalent, since boiling in SDS 
released both c~ and ~ chains from the aggregate. Since this 
material was immunoprecipitated with the conformation- 
specific YP3 Ab, it is apparent that preformed ot/~ dimers 
must enter the noucovalent aggregate. A second interaction 
appeared to be covalent, since a significant fraction of MS/ll4- 
reactive material remained in a high molecular weight band 
even after boiling (as long as no reducing agents were in- 
cluded during the incubation). Since this band was not de- 
tected using YP3, it is likely to represent free and thus mis- 
folded ~ chain bound via disulfide bonds to itsdf or possibly 
other ER proteins. Indeed, when transfected alone into COS 
cells, free ~ chain has recently been found to enter similar 
covalent aggregates  (48a). 
t~gardless of the precise nature of the high molecular 
weight complex, entry of newly synthesized r  dimers into 
the aggregate is likely to explain the inability of class II mol- 
ecules to be etficieutly transported out from the ER in the 
AIi cells. By complexing with resident ER proteins that bear 
specific sequence motifs for ER retention (49-52), class II 
molecules would similarly be retained in the ER. ER reten- 
tion may reflect either the sequestration  of high molecular 
weight complexes in subeompartments of the EK or inter- 
mediate compartment or a d  .ymmic retrieval process by which 
complexes are returned ("retrieved") back to the EK immedi- 
ately after exit into the intermediate compartment or CGN 
(41, 42, 46). Whereas the extent to which either possibility 
prevails in any specific  instance remains controverfial, our bio- 
chemical and immunocytochemical results are entirely con- 
sistent with both proposed mechanisms. 
As has been previously observed (25, 26), newly synthe- 
sized c~ and fl chains in ~li cells f~led to receive terminal 
modifications of their N-linked sugars, consistent with their 
f~ure to reach the medial Golgi complex or TGN (47). A 
significant fraction of at least the fl chain was subjected to 
our~ chain u-imming, but it could not be determined whether 
the increase in electrophoretic mobility observed reflected the 
activity of ER or Golgi glycosidases. More importantly, since 
immunofluorescence confoc~ microscopy of splenocytes has 
proved inadequate  to establish  the intracdlul~  localization 
of  class  II  molecules  in  AIi splenocytes  (26),  the  EM immu- 
nocytochemistry now provides clear and direct evidence to 
support a predominant localization to ER and other ER-like 
compartments  positive  for  BiP  (e.g.,  intermediate com- 
partmeut). 
Clearly, retention of the or//3 dimers in the ER is not com- 
plete in the AIi cells, since a small fraction of dass II mole- 
cules does reach the plasma membrane. As illustrated by the 
slow kinetics by which newly synthesized a or/~ ~hm~ exhibit 
molecular weight shifts corresponding to terminal glycosy- 
lation, it is obvious that the absence of li chain introduces 
a si~t  kinetic inh~ition of dass II transport to the Golgi 
complex. 
The Function of Ii Chain.  What, then, are the functions 
of Ii chain in splenocytes? Clearly, Ii chain is not required 
for initial folding or dimer formation, but it does appear to 
be required to complete the formation of class II molecules 
that the ER interprets as completely folded, properly assem- 
bled protein compleges. So, in this seuse, Ii chain can be viewed 
as providing an accessory folding or assembly function. Such 
a function must be distinguished from the activities associated 
with more "conventional" chaperones such as BiP or calnesfin 
which appear to act during the initial stages of protein folding. 
Whereas Ii chain has also been associated with preventing 
the premature loading of peptides onto class II molecules, 
it is evident that it is not absolutely required for this func- 
tion. At no stage of biosynthesis were SDS-stable, peptide- 
loaded complexes observed in All cells, although the ot/~ 
dirners formed were dearly competent to bind antigenic pep- 
tide at least after reaching the plasma membrane. Conceiv- 
ably, either the length of peptides  available in the ER, or 
the neutral pH environment of the ER lumen, was suflideut 
to prevent peptide loading in the secretory pathway.  The 
loading of peptides in endocytic organenes also did not occur, 
but this may reflect the inefficiency of class II transport out 
from the ER and/or the inability of or///dimers to reach 
the necessary elements of the endocytic pathway in the ab- 
sence of bound Ii chain. 
A substantial body of transfection data suggests that the 
cytoplasmic domain of Ii chain bears a targeting signal that 
either diverts class II molecules leaving the TGN to endo- 
somes (or specifies the rapid internalization of surface class 
II-Ii complexes) (15, 17). Thus, it seems likely that the in- 
ability of those ot/~ dimers that do escape the ER to acquire 
peptide or to mediate a class II-restricted response reflects 
the suggested targeting function of Ii chain. We have recently 
found that in B cells, newly synthesized class II molecules 
are not only diverted from the constitutive secretory pathway 
692  Ii Chain and MHC II Transport to endosomes but also appear to reach a novel compartment 
of MHC class II-containing vesicles (CIIV) where they may 
acquire peptide (Drake, J. R., et al., and Amigorena, S., et 
al., manuscripts submitted for publication). Conceivably, Ii 
may play a role in targeting from the TGN to endosomes 
or from endosomes to CIIV, or both. The detailed analysis 
of class II transport in AIi cells now provides the opportu- 
nity to address  directly each of these questions. 
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